testimonial title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum at turpis mauris. Interdum et malesuada fames ac ante ipsum primis in faucibus. In at tincidunt justo, eget commodo metus. Etiam commodo vehicula est lobortis elementum. Nunc consequat, mi ut dictum sagittis, justo diam ultrices diam, et ultricies lacus leo sit amet urna. Mauris pretium neque eget nibh eleifend, sit amet congue arcu ornare. Proin vestibulum quis sapien a suscipit. Vestibulum feugiat ante at purus venenatis, vitae sagittis odio ornare. Praesent turpis erat, iaculis tristique semper sed, pellentesque a neque. Nam vel velit non nisl mattis scelerisque. In dignissim purus libero, a suscipit mauris aliquet non. Cras scelerisque mattis justo eget malesuada.

Oliver Technow - Chief Executive Officer

  • Industry Master Degree from Frankfurt Chamber of Commerce, Frankfurt Germany.
  • More than 20 years of global pharmaceutical industry experience.
  • Held numerous leadership positions in commercial development, marketing and brand management, and lifecycle management and has extensive product launch and market access expertise in Europe and North America.
  • In 1997, joined Eisai GmbH in Frankfurt, Germany and in 2002, was appointed Director, CNS Business Unit; in 2006, was appointed Vice President, Head of Global Marketing for Eisai Inc. in Woodcliff Lake, NJ;  in 2011, was appointed Vice President, Established Products Business Unit; in 2013, was appointed President & General Manager for Eisai Limited in Mississauga, ON.
  • Appointed President of BIOVECTRA Inc., December 10, 2015.
  • Board Director for BIOTECanada
  • Member of the Steering Council of Innovative Medicines Canada (IMC)
  • In 2017, appointed to the Government of Canada’s Health/Bio-sciences Strategic Economic Table
  • In November 2019, promoted to Chief Executive Officer at BIOVECTRA
  • In June 2020, named new Chair of PEI BioAlliance Board of Directors